Clinical Outcomes of Acute Myeloid Leukemia Patients Harboring the RUNX1 Mutation: Is It Still an Unfavorable Prognosis? A Cohort Study and Meta-Analysis

Clinical Outcomes of Acute Myeloid Leukemia Patients Harboring the RUNX1 Mutation: Is It Still an Unfavorable Prognosis? A Cohort Study and Meta-Analysis

Acute myeloid leukemia (AML) with mutated <i>RUNX1</i> (<i>RUNX1</i><sup>mut</sup>) is considered to have an unfavorable prognosis. However, recent studies have reported comparable survival outcomes with wild-type <i>RUNX1</i> (<i>RUNX1</i>...

Full description

Bibliographic Details
Main Authors: Tarinee Rungjirajittranon, Theerapat Siriwannangkul, Smith Kungwankiattichai, Nattawut Leelakanok, Wannaphorn Rotchanapanya, Pongthep Vittayawacharin, Benjamaporn Mekrakseree, Kamolchanok Kulchutisin, Weerapat Owattanapanich
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Cancers
Subjects:
acute myeloid leukemia
genetic
molecular
mutation
next-generation sequencing
<i>RUNX1</i>
Online Access:https://www.mdpi.com/2072-6694/14/21/5239

Internet

https://www.mdpi.com/2072-6694/14/21/5239

Similar Items